Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

ABPI to Take Lead Role in Representing Vaccine Industry

Published: Tuesday, May 21, 2013
Last Updated: Tuesday, May 21, 2013
Bookmark and Share
The ABPI announced that it will now represent the vaccine industry to Government and healthcare stakeholders.

A new ABPI Vaccine Group has been formed today and will work in partnership with the public health community to support the development and implementation of successful UK immunisation programmes. The group is made up of six members - Abbott Healthcare Products Ltd, AstraZeneca, GSK, Janssen, Novartis, Pfizer.

UVIG, which has represented the vaccine industry for over a decade, has been disbanded.

Vaccinations are important because they protect the public from preventable disease, thereby helping save lives and prevent ill health whilst minimising the costs to the health service of non-immunisation. According to the World Health Organisation, vaccines help to prevent more than 2.5 million deaths each year across the world that would otherwise occur without vaccination.

Stephen Whitehead, Chief Executive of the ABPI, said:

"I am delighted that the ABPI will be taking a leading role in representing the vaccines industry to Government and other healthcare stakeholders. This addition to the ABPI strengthens the unity of the bio-pharmaceutical industry and further underlines the ABPI’s position as the leading life sciences trade association in the UK. Vaccinations against disease play a vital role in improving public health and help protect us from preventable illnesses. I am immensely proud of the work pharmaceutical companies do to bring these medicines to people across the world."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Designing Better Drugs
A rational drug engineering approach could breathe new life into drug development.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Factors Influencing Influenza Vaccine Effectiveness Uncovered
The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests.
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
New Model to Enhance Zika Virus Research
The model will allow researchers to better understand how the virus causes disease and aid in the development of antiviral compounds and vaccines.
Improving Flu Vaccine Effectiveness
NIH study finds factors that may influence influenza vaccine effectiveness.
BMS’s Opdivo Clinical Trial Shows Promise
Safety profile of the combination regimen from CheckMate -069 was consistent with previously reported studies and adverse events were managed using established safety algorithms.
CNS Inflammation: A Pathway and Possible Drug Target
Scientists have long known that the central nervous system (CNS) has a remarkable ability to limit excessive inflammation in the presence of antigens or injury, but how it works has been unclear.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!